Продукция

Search by alphabet

  • Fluidoum 

    ATC GROUPS: A13 RESTORATIVES

    It activates central nervous system, improves physical activity and mental capacity, enhances visual acuity, stimulates metabolism and adaptogenic body properties, normalizes sugar content in blood, increases appetite, activates functions of female and male reproductive glands, makes body resistant to adverse factors of the external environment.

  • Escuven 

    ATC GROUPS: C05 VASOPROTECTORS

    New vasoprotective medicinal product manufactured by the Ternopharm Company. Escuven gel contains escin – a substance originally synthesized from buckeye seeds. Escuven gel has anti-inflammatory and anti-exudative effects; it protects blood capillaries and veins, improves vessel wall tonus, decreases lymphedema, removes venous stasis, as well as it accelerates dispersion of posttraumatic and postsurgical blood tumours.

  • Tunctura echinacea

    ATC GROUPS: L03 IMMUNE STIMULATORS

    It is used for treatment of immune deficiency, chronic recurrent inflammatory diseases of various localization, for treatment of ARVI initial symptoms, within long-term administration of antibiotics, topical treatment of wounds, which can not be healed for a long time.

  • Echinaceae tinctura-Ternopharm

    ATC GROUPS: L03 IMMUNE STIMULATORS

    It is used for treatment of immune deficiency, chronic recurrent inflammatory diseases of various localization, for treatment of ARVI initial symptoms, within long-term administration of antibiotics, topical treatment of wounds, which can not be healed for a long time.

  • Escuven 

    ATC GROUPS: C05 VASOPROTECTORS

    New vasoprotective medicinal product manufactured by the Ternopharm Company. Escuven gel contains escin – a substance originally synthesized from buckeye seeds. Escuven gel has anti-inflammatory and anti-exudative effects; it protects blood capillaries and veins, improves vessel wall tonus, decreases lymphedema, removes venous stasis, as well as it accelerates dispersion of posttraumatic and postsurgical blood tumours.